Plasmapheresis Collection Systems

Description

SNBTS requires Automated Plasmapheresis Collection Machines which must: - Be capable of providing leuco-depleted plasma for the manufacture of Covid-19 Convalescent Plasma(C19-CP), Fresh Frozen Plasma and Source plasma for blood products. - These devices should enable the collection of double and triple doses of CP and FFP - These must be in line with Guidelines for the Blood Transfusion Services in the UK (Current Edition) and the Blood Safety & Quality Regulations 2005. SNBTS requires Automated Plasmapheresis Collection Machines which must: - Be capable of providing leuco-depleted plasma for the manufacture of Covid-19 Convalescent Plasma(C19-CP), Fresh Frozen Plasma and Source plasma for blood products. - These devices should enable the collection of double and triple doses of CP and FFP - These must be in line with Guidelines for the Blood Transfusion Services in the UK (Current Edition) and the Blood Safety & Quality Regulations 2005. This technology is required to embed the skills required to collect C19-CP for the remainder of the current pandemic and in any future outbreak or wave. It is therefore envisioned that the machines will operate in two modes: - Tick Over: Where the centres will collect available C19-CP to around 84 procedures per week. During this phase any spare collection slots will be utilized to balance the inventory by collecting FFP - Flex Up: Where there is a significant outbreak of Covid19 either locally or nationally the services will extend collection and build to 204 procedures per week. - For planning purposes, we have assumed that there will be one period of 13 weeks at this higher level - It is also assumed that we would have a 4-6 week lead time to operate at this higher level - Companies are therefore asked to consider how they might support SNBTS while operating at higher level and how they would supply the additional disposables to support this operation.